Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

KATHERINE ROSE MAIORISI

Physician Assistants & Advanced Practice Nursing Providers Physician Assistant

NPI
1265058044
CMS profile
10823945
Location
PAWTUCKET, RI

General Payments · PY2021–2024

$653.44

  • Reported across 36 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$309.66

16 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $309.66 16

By paying entity

PY2024 · sorted by reported total

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2021 $75.49 5
PY2022 $69.46 4
PY2023 $198.83 11
PY2024 $309.66 16

Payment records · PY2024 (16)

Sorted by paying entity, then date · as published by CMS

Program year 2024 202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $26.96 03/05/2024 Food and Beverage Undisputed 01/23/2026 1107579139 CMS
ABBVIE INC. $14.35 10/29/2024 Food and Beverage Undisputed 01/23/2026 1107579141 CMS
Alnylam Pharmaceuticals Inc. $17.50 03/26/2024 Food and Beverage Undisputed 01/23/2026 1125837317 CMS
Amgen Inc. $16.70 07/11/2024 Food and Beverage Undisputed 01/23/2026 1117316954 CMS
AstraZeneca Pharmaceuticals LP $23.81 06/26/2024 Food and Beverage Undisputed 01/23/2026 1105871675 CMS
AstraZeneca Pharmaceuticals LP $17.99 09/19/2024 Food and Beverage Undisputed 01/23/2026 1105874435 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $25.73 04/23/2024 Food and Beverage Undisputed 01/23/2026 1117938049 CMS
Corcept Therapeutics $23.38 10/08/2024 Food and Beverage Undisputed 01/23/2026 1117765819 CMS
Exact Sciences Corporation $17.00 06/20/2024 Food and Beverage Undisputed 01/23/2026 1114552016 CMS
Lilly USA, LLC $16.28 02/06/2024 Food and Beverage Undisputed 01/23/2026 1135764339 CMS
Mylan Specialty L.P. $15.24 02/26/2024 Food and Beverage Undisputed 01/23/2026 1147284892 CMS
PFIZER INC. $20.63 06/12/2024 Food and Beverage Undisputed 01/23/2026 1131789081 CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC $21.14 03/06/2024 Food and Beverage Undisputed 01/23/2026 1153427503 CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC $17.19 04/25/2024 Food and Beverage Undisputed 01/23/2026 1153674800 CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC $17.19 06/13/2024 Food and Beverage Undisputed 01/23/2026 1153672491 CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC $18.57 11/27/2024 Food and Beverage Undisputed 01/23/2026 1153514310 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.